Muscarinic M1 Acetylcholine Receptor Neurons
Overview
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Muscarinic M1 Acetylcholine Receptor Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>CHRM1 (chromosome 11q13)</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>460 amino acids</td>
</tr>
<tr>
<td class="label">Mass</td>
<td>~51 kDa</td>
</tr>
<tr>
<td class="label">Transmembrane domains</td>
<td>7</td>
</tr>
<tr>
<td class="label">Signal transduction</td>
<td>Gq/11-coupled</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Relative Expression</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>M1R Location</td>
</tr>
<tr>
<td class="label">Pyramidal neurons (L2/3)</td>
<td>Somatodendritic</td>
</tr>
<tr>
<td class="label">Pyramidal neurons (L5)</td>
<td>Somatodendritic</td>
</tr>
<tr>
<td class="label">Interneurons</td>
<td>Somatodendritic</td>
</tr>
<tr>
<td class="label">Layer 5 corticospinal neurons</td>
<td>Dendritic</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>M1R Function</td>
</tr>
<tr>
<td class="label">Medium spiny neurons D1</td>
<td>Inhibit DAT, increase DA</td>
</tr>
<tr>
<td class="label">Medium spiny neurons D2</td>
<td>Indirect pathway modulation</td>
</tr>
<tr>
<td class="label">Cholinergic interneurons</td>
<td>Autoreceptor function</td>
</tr>
<tr>
<td class="label">Oscillation</td>
<td>Frequency</td>
</tr>
<tr>
<td class="label">Gamma</td>
<td>30-80 Hz</td>
</tr>
<tr>
<td class="label">Theta</td>
<td>4-8 Hz</td>
</tr>
<tr>
<td class="label">Alpha</td>
<td>8-12 Hz</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">HTL-0018318</td>
<td>Orthosteric agonist</td>
</tr>
<tr>
<td class="label">KarXT (xanomeline + trospium)</td>
<td>M1/M4 agonist</td>
</tr>
<tr>
<td class="label">GSK-103470</td>
<td>Partial agonist</td>
</tr>
<tr>
<td class="label">AZD-8529</td>
<td>Positive allosteric modulator</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>M1R Mechanism</td>
</tr>
<tr>
<td class="label">Donepezil</td>
<td>↑ ACh → ↑ M1R activation</td>
</tr>
<tr>
<td class="label">Rivastigmine</td>
<td>↑ ACh → ↑ M1R activation</td>
</tr>
<tr>
<td class="label">Galantamine</td>
<td>↑ ACh + allosteric nAChR</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Type</td>
</tr>
<tr>
<td class="label">CHRM1</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">Phospho-CREB</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">c-Fos</td>
<td>IEG</td>
</tr>
<tr>
<td class="label">Gq/11α</td>
<td>G protein</td>
</tr>
<tr>
<td class="label">PLCβ1</td>
<td>Enzyme</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Interaction with M1R</td>
</tr>
<tr>
<td class="label">Anticholinergics</td>
<td>M1R blockade</td>
</tr>
<tr>
<td class="label">Benzodiazepines</td>
<td>↓ ACh release</td>
</tr>
<tr>
<td class="label">Antipsychotics</td>
<td>Varying M1R affinity</td>
</tr>
<tr>
<td class="label">Opioids</td>
<td>↓ ACh release</td>
</tr>
</table>
Muscarinic M1 acetylcholine receptor (M1R) neurons express the M1 subtype of muscarinic cholinergic receptors, which mediate critical cognitive functions including learning, memory consolidation, attention, and cortical activation. M1R signaling is profoundly impaired in Alzheimer's disease and represents a major therapeutic target for cognitive enhancement in neurodegenerative disorders.[@hasselmo2006]
Mermaid diagram (expand to render)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
- [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
- [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Molecular Biology
M1 Receptor Structure
The M1 receptor is a class A GPCR with distinctive features:[@haga2013]
Signaling Mechanisms
M1R activation triggers multiple downstream pathways:[@felder1998]
Classical Gq Pathway:
- Phospholipase Cβ activation
- PIP2 hydrolysis to IP3 and DAG
- Intracellular Ca2+ release
- PKC activation
Ion Channel Modulation:
- Inhibition of KCNQ/Kv7 (M-current) → increased excitability
- Inhibition of SK channels → altered afterhyperpolarization
- Enhancement of NMDA receptor function
Gene Expression:
- CREB phosphorylation
- BDNF transcription
- Immediate early gene induction
Receptor Distribution
M1R is the most abundant muscarinic receptor in the brain:[@levey1996]
Neuroanatomical Distribution
Cortical Neurons
M1R is expressed on diverse cortical neuron populations:[@dasilva2021]
Hippocampal Neurons
M1R modulates hippocampal circuits:[@hasselmo2006a]
- CA1 pyramidal neurons: M1R on dendrites, LTP enhancement
- CA3 pyramidal neurons: Pattern separation/completion
- Dentate granule cells: M1R on proximal dendrites
- Interneurons: M1R-mediated disinhibition
Striatal Neurons
M1R on striatal neurons modulates motor control:[@bonsi2011]
Physiological Functions
Synaptic Plasticity
M1R activation enhances synaptic plasticity:[@seeger2004]
Long-Term Potentiation (LTP):
- Removes Mg2+ block from NMDA receptors
- Enhances Ca2+ influx during tetanic stimulation
- Promotes AMPA receptor insertion
Long-Term Depression (LTD):
- M1R required for some LTD forms
- Endocannabinoid release modulation
- Metaplasticity regulation
Spine Plasticity:
- Promotes spine formation
- Enhances spine stability
- Critical for memory encoding
Network Oscillations
M1R shapes cortical rhythms:[@fisahn2002]
Attention and Arousal
M1R mediates cholinergic attention:[@herrero2008]
- Top-down attention enhancement
- Signal-to-noise ratio improvement
- Cue detection facilitation
- Sustained attention maintenance
Role in Neurodegeneration
Alzheimer's Disease
M1R dysfunction is central to AD pathophysiology:[@fisher2008]
Cholinergic Deficit:
- Loss of basal forebrain cholinergic neurons
- Reduced ACh release
- M1R signaling impairment
Amyloid-β Effects on M1R:
- Aβ oligomers disrupt M1R-G protein coupling
- Reduced M1R surface expression
- Impaired downstream signaling
Tau Pathology:
- Hyperphosphorylated tau disrupts M1R localization
- M1R signaling affects tau phosphorylation via GSK-3β
- Bidirectional relationship
Cognitive Correlates:
- M1R binding reduced in AD cortex
- Correlation with cognitive decline severity
- Early marker of cholinergic dysfunction
Parkinson's Disease
M1R in PD cognitive impairment:[@bohnen2022]
- Cognitive Deficits: M1R contributes to executive dysfunction
- Dementia Risk: Reduced M1R binding in PD-D
- Hallucinations: Altered M1R signaling in visual cortex
- Motor-Cognitive Link: Striatal M1R for procedural learning
Lewy Body Dementia
M1R involvement in LBD:[@teaktong2005]
- Fluctuating cognition linked to M1R variability
- Visual hallucinations from occipital M1R changes
- Greater cholinergic deficit than AD
- Target for cholinesterase inhibitors
Huntington's Disease
M1R dysfunction in HD:[@van2007]
- Reduced M1R expression in striatum
- Motor learning impairment
- Cognitive decline correlation
- Potential therapeutic target
Therapeutic Targeting
M1 Agonists in Development
Multiple M1-selective agonists are in clinical development:[@moran2018]
Cholinesterase Inhibitors
Current AD therapies enhance M1R signaling indirectly:[@anand2013]
Advantages of Direct M1 Targeting
Selective M1 agonists offer advantages:[@kruse2017]
- Reduced peripheral side effects (M2/M3 avoided)
- Enhanced cognitive specificity
- Potential disease-modifying effects (neurotrophic)
- Synergy with other therapies
Non-Pharmacological Approaches
M1R function can be enhanced by:[@connelly2009]
- Deep brain stimulation of cholinergic nuclei
- Transcranial magnetic stimulation
- Cognitive training (endogenous ACh release)
- Exercise (increases BDNF, cholinergic tone)
Molecular Markers
Clinical Assessment
Cognitive Testing
M1R-related cognitive domains:[@bentley2004]
- Episodic memory (hippocampal)
- Working memory (prefrontal)
- Attention and processing speed
- Executive function
Imaging Biomarkers
- PET ligands for M1R binding (under development)
- fMRI: M1R-mediated network activation
- Cholinergic PET (VAChT, AChE)
Drug Interactions
- Alzheimer's disease
- Layer 5 corticospinal neurons
- Dentate granule cells
- Medium spiny neurons
- basal forebrain cholinergic neurons
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Pathway Diagram
The following diagram shows the key molecular relationships involving Muscarinic M1 Acetylcholine Receptor Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)